United States and Plaintiff States v. Live Nation Entertainment et al (S.D.N.Y. 1:24-CV-03973-AS)

Forty attorneys general joined the U.S. Department of Justice in a lawsuit against Live Nation Entertainment, Inc. and its subsidiary, Ticketmaster L.L.C.  The lawsuit alleges that Live Nation has undertaken anticompetitive conduct in various markets across the live concert ecosystem to maintain its monopoly positions in the markets for primary ticketing services for major concert…

Read More →

Bipartisan Coalition Urges Congress to Take Action Against Rise in Organized Retail Crime

Organized retail crime has contributed to financial losses totaling over $121 billion in the U.S., and 76 percent of retail asset protection managers report their employees have suffered from violence at the hands of an organized retail criminal.

Read More →

State and Territory Attorneys General Urge FDA to Take Action Against Counterfeit and Illegally Sold GLP-1 Drugs

Washington, D.C.– The National Association of Attorneys General (NAAG) sent a letter on behalf of a bipartisan coalition of 38 state and territory attorneys general which calls on the Food and Drug Administration (FDA) to take decisive action against the unlawful sale and distribution of counterfeit and illegally sold GLP-1 drugs, including Mounjaro, Zepbound, Ozempic, and…

Read More →

A Bipartisan Coalition of 47 Attorneys General Call on the FCC to Strengthen the Robocall Mitigation Database

To strengthen the Robocall Mitigation Database (RMD) so that providers understand what information they need to submit and have deadlines to submit this information

Read More →

Bipartisan Coalition of 44 State and Territory Attorneys General Endorse the Child Exploitation and Artificial Intelligence Expert Commission Act of 2024

The National Association of Attorneys General (NAAG) sent a letter to Rep. Nick Langworthy (R-NY) and U.S. House leadership on behalf of a bipartisan coalition of 44 state and territory attorneys general endorsing the Child Exploitation and Artificial Intelligence Expert Commission Act of 2024.

Read More →

41 Attorneys General Call On Meta To Protect Users’ Accounts From Scammers

The National Association of Attorneys General (NAAG) sent a letter to Meta Platforms, Inc. (Meta) on behalf of a bipartisan coalition of 41 attorneys general that addresses the recent rise of Facebook and Instagram platform account takeovers by scammers and frauds. Account takeovers are when bad actors break into a user’s account and change passwords,…

Read More →

54 Attorneys General Call on Congress to Study AI and Its Harmful Effects on Children

A bipartisan coalition of 54 state and territory attorneys general urge Congress to study how artificial intelligence (AI) can and is being used to exploit children through child sexual abuse material (CSAM). The attorneys general also asked Congress to propose legislation that would protect children from those abuses. The National Association of Attorneys General (NAAG)…

Read More →

Bipartisan Coalition of Attorneys General Express Support for the G.U.A.R.D. VA Act

A bipartisan coalition of 44 attorneys general express support for the passage of legislative proposals included in Governing Unaccredited Representatives Defrauding (G.U.A.R.D.) Veterans Affairs (VA) Benefits Act. In a letter to congressional leaders, the attorneys general explain that the passing of the bipartisan legislation would hold unaccredited and unregulated actors accountable for targeting and preying…

Read More →

Attorneys General Call on Congress to Pass the Combating Illicit Xylazine Act

A bipartisan coalition of 39 state and territory attorneys general called on leaders of Congress to pass the Combating Illicit Xylazine Act (H.R.1839/S.993). Xylazine is only approved by the U.S. Food and Drug Administration (FDA) as a veterinary medicine and in humans, it is known to depress breathing and heart rate, lower blood pressure, and…

Read More →

Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)

44 plaintiff states filed suit against Teva Pharmaceuticals and 19 of the nation’s largest generic drug manufacturers alleging a broad conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs. The lawsuit was originally Connecticut, was transferred to the MDL court in Pennsylvania.  The lawsuit…

Read More →